Integra Lifesciences Holdings (IART) Price to FCF (2009 - 2026)

Integra Lifesciences Holdings has disclosed Price to FCF across 18 years of filings, most recently posting 133.09 for Q2 2026.

• In Q2 2026, Price to FCF rose 256.3% year-over-year to 133.09; the TTM figure through Jun 2026 stood at 54.14 (up 311.93% YoY), while the FY2025 annual figure was 31.17, down 144.43% from the prior year.
• Price to FCF came in at 133.09 for Q2 2026 at Integra Lifesciences Holdings, up from 145.26 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 9599.48 in Q1 2024 to a low of 195.79 in Q3 2024.
• Average Price to FCF over 5 years is 596.46, with a median of 80.95 recorded in 2024.
• Year-over-year, Price to FCF surged 2442.1% in 2024 and plunged 316.46% in 2025.
• Over 5 years, Price to FCF stood at 64.58 in 2022, then surged by 54.17% to 99.56 in 2023, then decreased by 16.79% to 82.84 in 2024, then slumped by 316.46% to 179.32 in 2025, then surged by 174.22% to 133.09 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 133.09 in Q2 2026, 145.26 in Q1 2026, and 179.32 in Q4 2025.